ChoA Pharmaceutical Co., LTD. (KOSDAQ: A034940)
Health Care · Pharmaceuticals · KR
₩2,570.00
-3.20% today · -53.5% 1Y
ChoA Pharmaceutical Co., LTD. (KOSDAQ: A034940) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.84M.
Over the last twelve months the share price has lost 53.5%, trading between 2.48K and 5.92K.
Tweenvest scores ChoA Pharmaceutical Co., LTD. across four factors: quality 55/100, value 62/100, growth 0/100. Its strongest factor is value.
A034940 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.84M
- Revenue (TTM)
- $39.49M
- P/E
- —
- EPS
- -453.69
- Dividend yield
- —
- Beta (5Y)
- 0.54
- 52-week high
- ₩5,920.00
- 52-week low
- ₩2,485.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.20M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Krebs Biochemicals & Industries LimitedBSE: 524518 | $12.41M | Rs55.72 | -19.71% |
| Liven Pharma LimitedKASE: LIVEN | $12.40M | PKRs30.37 | -2.47% |
| Alpa Laboratories LimitedNSEI: ALPA | $12.39M | Rs56.99 | -3.83% |
| Rize Oncology Inc.OTCPK: RZON.F | $12.12M | $— | — |
| Daré Bioscience, Inc.NasdaqCM: DARE | $11.82M | $0.75 | -3.03% |
| Hepion Pharmaceuticals, Inc.OTCPK: HEPA | $11.79M | $0.12 | +48.15% |
| AcuCort AB (publ)XSAT: ACUC | $11.70M | Skr0.40 | -19.88% |
| Argenica Therapeutics LimitedASX: AGN | $11.65M | AU$0.13 | -13.33% |
Figures last refreshed Oct 11, 2026.